I don't think people are assuming that at all, but the sooner it's approved people can start being treated, i.e. sales.
If it's not approved it's not approved, but this is still a very positive step. Dead people can't buy Remestemcel-L, and the chance to bring it to market in the midst of the Coronavirus pandemic is better than after it has passed.
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-184
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32370 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 60258 | 5 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |